Suppr超能文献

[三级医院社区获得性产超广谱β-内酰胺酶肠杆菌科细菌引起的尿路感染——一项回顾性研究]

[Urinary Tract Infections Caused by Community-Acquired Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in a Level III Hospital - A Retrospective Study].

作者信息

Simões Ana, Lima Margarida, Brett Ana, Queiroz Carolina, Chaves Catarina, Oliveira Henrique, Januário Luís, Rodrigues Fernanda

机构信息

Serviço de Urgência e Unidade de Infeciologia. Hospital Pediátrico. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal.

Faculdade de Medicina. Universidade de Coimbra. Coimbra. Portugal.

出版信息

Acta Med Port. 2020 Jul 1;33(7-8):466-474. doi: 10.20344/amp.12338. Epub 2019 Nov 26.

Abstract

INTRODUCTION

The emergence of β-lactamases producing bacteria is a problem worldwide, with increasing importance in communityacquired infections, especially in urinary tract infections. Data regarding the use of non-carbapenem antimicrobials in these infections are scarce. The aim of this study was to analyse the treatment and outcome of urinary tract infections caused by community-acquired β-lactamase-producing bacteria in children.

MATERIAL AND METHODS

Retrospective study performed in a level III paediatric hospital, between June 2007 and December 2017. All children with β-lactamase-producing Enterobacteriaceae identified in aseptically collected urine culture were included.

RESULTS

A total of 175 urinary infections caused by β-lactamases producing bacteria were diagnosed, 34 (19%) were community-acquired: 25 Escherichia coli (74%), 4 Klebsiella pneumoniae (12%), 4 Proteus mirabilis (12%) and 1 Proteus vulgaris (3%). In 30 (88%) cases, it was the first urinary infection. After identification of the microorganism and antimicrobial susceptibility, 33 (97%) children were re-evaluated and 24 (71%) had a repeat urine culture, which was positive in three (13%). In six (18%) cases, antibiotic treatment was modified. Four (12%) children had another UTI in the following month. In 30 (88%) children, imaging was carried out, with no nephrourological malformations detected.

DISCUSSION

In the last decade, about 20% of urinary infections caused by β-lactamase-producing Enterobacteriaceae were community-acquired with a relatively stable number of cases over the years. No nephro-urological malformations were identified in these children.

CONCLUSION

Although the number of cases is small, the clinical and microbiological outcomes showed that most were successfully treated with non-carbapenem antibiotics, with low recurrence of new episodes of urinary tract infections.

摘要

引言

产β-内酰胺酶细菌的出现是一个全球性问题,在社区获得性感染中愈发重要,尤其是在尿路感染方面。关于在这些感染中使用非碳青霉烯类抗菌药物的数据稀缺。本研究的目的是分析儿童社区获得性产β-内酰胺酶细菌引起的尿路感染的治疗及转归。

材料与方法

在一家三级儿科医院于2007年6月至2017年12月进行的回顾性研究。纳入所有在无菌采集的尿培养中鉴定出产β-内酰胺酶肠杆菌科细菌的儿童。

结果

共诊断出175例由产β-内酰胺酶细菌引起的尿路感染,其中34例(19%)为社区获得性:25例大肠埃希菌(74%),4例肺炎克雷伯菌(12%),4例奇异变形杆菌(12%)和1例普通变形杆菌(3%)。在30例(88%)病例中,这是首次尿路感染。在鉴定出微生物及抗菌药物敏感性后,33例(97%)儿童接受了重新评估,24例(71%)进行了重复尿培养,其中3例(13%)结果为阳性。6例(18%)病例的抗生素治疗进行了调整。4例(12%)儿童在接下来的月份发生了另一次尿路感染。30例(88%)儿童进行了影像学检查,未检测到肾泌尿系统畸形。

讨论

在过去十年中,约20%由产β-内酰胺酶肠杆菌科细菌引起的尿路感染为社区获得性,且多年来病例数相对稳定。在这些儿童中未发现肾泌尿系统畸形。

结论

尽管病例数较少,但临床和微生物学结果显示,大多数患者用非碳青霉烯类抗生素治疗成功,尿路感染新发作的复发率较低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验